<DOC>
	<DOCNO>NCT00383578</DOCNO>
	<brief_summary>This study design demonstrate efficacy safety vildagliptin compare metformin elderly drug naive patient type 2 diabetes</brief_summary>
	<brief_title>Efficacy Safety Vildagliptin Compared Metformin Elderly Drug Naive Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 65 year upper age limit recommend local prescribing information metformin Drug naive patient type 2 diabetes . Body mass index ( BMI ) range 2240 kg/m2 . HbA1c range 7 9 % inclusive FPG &lt; 270 mg/dL ( 15 mmol/L ) A history type 1 diabetes Evidence significant diabetic complication Treatment insulin oral antidiabetic agent Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
	<keyword>hemoglobin A1c</keyword>
	<keyword>metformin</keyword>
</DOC>